Browse > Article
http://dx.doi.org/10.13048/jkm.19044

A case of Advanced Gastric cancer patient treated by Korean Medicine monotherapy  

Kim, Sulki (Dept. of East-West Cancer center, Department of Internal Medicine, Dunsan Korean Medicine Hospital of Daejeon University)
Son, Changgue (Dept. of East-West Cancer center, Department of Internal Medicine, Dunsan Korean Medicine Hospital of Daejeon University)
Choi, Inwoo (Department of Internal Medicine, Dunsan Oriental Hospital of Daejeon University)
Park, Sojung (Dept. of East-West Cancer center, Department of Internal Medicine, Dunsan Korean Medicine Hospital of Daejeon University)
Publication Information
The Journal of Korean Medicine / v.40, no.4, 2019 , pp. 91-100 More about this Journal
Abstract
Objectives: The present study reports case of an advanced gastric cancer patient who did not receive resection and was treated with Korean Medicine (KM) monotherapy. Methods: A 59-year-old female patient diagnosed with advanced gastric cancer visited the Dunsan Korean medicine Hospital of Daejeon University on April 15, 2018 for the Korean medicine treatment. The patient was treated with KM for approximately 1 year, from May, 2018 to May, 2019. Computed tomography (CT) was used to follow-up of the tumor site. Laboratory analysis and National Cancer Institute Common Terminology Criteria for Adverse Event (NCI-CTCAE), version 5.0 were used to evaluate the safety of our treatment. Results: The patient's quality of life (QOL) and related symptoms improved during the treatment. Conclusion: This study suggests that KM may help to improve QOL of advanced gastric cancer patients. This is a valuable report that shows the natural history of Korean gastric cancer invasion to deeper layers over time.
Keywords
Advanced gastric cancer; Korean medicine; acupuncture; Samchilchoongcho-Jung; Geonchil-Jung; Gongjin-Dan;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Son MJ, Im HJ, Ku BC, Lee JW, Jung SY, Kim YE, et al. An Herbal Drug, Gongjin-dan, Ameliorates Acute Fatigue Caused by Short-Term Sleep-Deprivation: A Randomized, Double-Blinded, Placebo-Controlled, Crossover Clinical Trial. Frontiers in Pharmacology. 2018;9,479.   DOI
2 Park EH, Kim YJ, Noriko Y, Park SH, Kim HK, Jang HJ, et al. Stereospecific anticancer effects of ginsenoside Rg3 epimers isolated from heat-processed American ginseng on human gastric cancer cell. Journal of Ginseng Research. 2014;38:22-27.   DOI
3 Kang SW, Min HY. Ginseng, the 'immunity Boost':The Effect of Panax ginseng on Immune System. Journal of Ginseng Research. 2012;36(4) 354-368.   DOI
4 Xiao JH, Chen DX, Fang N, Liu ZL, Zhang T. Growth arrest of human gastric adenocarcinoma cells by bioactive compounds of Cordyceps jiangxiensis(CaoMuWang) through induction of apoptosis. Journal of Food, Agriculture& Environment. 2006;4:66-73.
5 Zhang YS, XIe JZ, Zhong JL, Li YY, Wang RQ, Qin YZ, et al. Acetyl-11-keto-${\beta}$-boswellic acid (AKBA) inhibits human gastric carcinoma growth through modulation of the Wnt/${\beta}$-catenin signaling pathway. Biochimica et Biophysica Acta. 2013;1830(6):3604-3615.   DOI
6 Choi WC, Jung HS, Kim KS, Lee SK, Yoon SW, Park JH, et al. Rhus verniciflua Stokes against Advanced Cancer: A Perspective from the Korean Integrative Cancer Center. Journal of Biomedicine and Biotechnology. 2012;874276. Available from: URL: https://www.hindawi.com/journals/bmri/2012/874276/
7 Lee SH, Choi WC, Kim KS, Park JW, Lee SH, Yoon SW. Shrinkage of Gastric cancer in an elderly Patient Who Received Rhus verniciflua Strokes Extract. The Journal of Alternative and Complementary Medicine. 2010;16(4):497-500.   DOI
8 Charlotte H Y Lau, Edwin P Hui, Alexander Y L Lau. Acupuncture and Related Therapies for Symptom Management in Palliative Cancer Care: Systematic Review and Meta -Analysis: Erratum. Medicine(Baltimore). 2016;95(20):e90e6.   DOI
9 Choi JE, Cho CK, Lee YW, Yoo HS, Lu Weidong, Elizabeth DC, et al. The Value of Acupuncture in Cancer Care. Journal of Korean Traditional Oncology. 2010;15(1),1-17.
10 National Institute of Oriental Medicine Co-author, Meridian and Acupointology. 6th ed. Daejeon: Jonglyeonamu; 2012, p.64, 214, 231, 236, 247.
11 Tsukuma H, Oshima A, Narahara H, Morii T. Natural history of early gastric cancer: a non-concurrent, long term, follow up study. Gut. 2000;47:618-621.   DOI
12 Tomohiro I, Masao Y, Hiroyuki O, Naomi K, Kohei T, Masaki T, et al. Natural History of Early Gastric Cancer: a Case Report and Literature Review. Journal of Gastric Cancer. 2017;17(1):88-92.   DOI
13 Junko F, Toshifusa N, Toshiaki H, Yorimasa Y, Akiyoshi I, Tomohiro T, et al. Natural history of gastric cancer-a case followed up for eight years: early to advanced gastric cancer. Clinical Journal of Gastroenterology. 2012;5:351-354.   DOI
14 Chung HW, Son DK, Ji JS, Chung DY, Chung JS, Kim JI, et al. A case of Spontaneous Regression of Advanced Gastric Cancer. Journal of Korean Gastrointestinal Endoscopy. 2013;27:216-219.
15 Yang SE, Lee YJ, Lee JA, Kim SH, Jung SH, Kim anna, et al. A Patient with Distinct Evidences of Spontaneous Regression and Recurrence of Gastric Cancer for 13 Years. Journal of Korean Gastrointestinal Endoscopy. 2012;16(3):149-152.
16 Kim JH, Choi JY. Postoperative Changes in Body Weight, Anxiety, Depression, and Quality of Life after Radical Gastrectomy among Patients with Gastric Cancer. Korean Oncology Nursing Society. 2014;14(3):139-145.
17 National Cancer Information Center. Cancer to see with statistics. Available from : URL: https://www.cancer.go.kr/lay1/S1T639C640/contents.do
18 Lee JH, Kim JG, Jung HK, Kim JH, Jeong WK, Jeon TJ et al. Synopsis on Clinical Practice Guideline of Gastric Cancer in Korea: An Evidence-Based Approach. Korean Journal of Gastroenterology. 2014;63(2):66-81.   DOI
19 Park SH, Lee SI. Recent Advances in Chemotherapy of Gastric Cancer. The Korean Journal of Medicine. 2012;82(4):417-426.   DOI
20 Park SH, Cho MS, Kim YS, Hong J, Nam E, Park J, et al. Self-reported health-related quality of life predicts survival for patients with advanced gastric cancer treated with first-line chemotherapy. Quality of Life Research. 2008;17(7):1043-4.   DOI
21 Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, sargent D, Ford R. New response evaluation criteria in solid tumors: Revised RECIST guideline(version1.1). European journal of cancer. 2009;45:228-247.   DOI
22 National Cancer Institue, Common Terminology Criteria for Adverse Events(CTCAE) v.5.0,2017. Available from : URL: https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_5.0/